ILLUMINA VENTURES

ILLUMINA VENTURES is a Pre-seed, Seed and Series A fund in the US and Europe writing $10M–$50M checks into AI, Healthcare, genomics, precision-health, life-sciences, diagnostics, therapeutics, biotechnology, life-science-tools and synthetic-biology.

Stages: Pre-seed, Seed, Series A
Sectors: AI, Healthcare, genomics, precision-health, life-sciences, diagnostics, therapeutics, biotechnology, life-science-tools, synthetic-biology
Check size: $10M–$50M
Invests in: US-wide, Europe
Round role: Leads rounds
Actively investing: Yes
Founded: 2016
Assets under management: $560M

Thesis

Illumina Ventures is an independently managed venture capital firm established in 2016, focusing on early-stage companies in genomics, precision health, and life sciences. They leverage a strategic relationship with Illumina, Inc. to identify and support innovative startups. Their investment thesis centers on advancing human health through breakthroughs in genomics and nucleic acid sequencing technologies, targeting companies in life science tools, diagnostics, therapeutics, and digital health, with an interest in AI, machine learning, and synthetic biology. The firm primarily invests in Series A rounds, but also engages in seed and pre-seed stages through Illumina Ventures Labs. They often take a lead investor role, providing capital, mentorship, and operational support. Their geographic scope includes the United States and Europe, with a global investment outlook. As of September 2021, they manage $560 million in capital, with their second fund closing at $325 million. Typical check sizes range from $10 million to $50 million. The firm is headquartered in Foster City, California.

Common questions

Does ILLUMINA VENTURES invest at the Pre-seed stage?

Yes. ILLUMINA VENTURES lists Pre-seed, Seed and Series A among the stages it invests in.

What check size does ILLUMINA VENTURES write?

ILLUMINA VENTURES writes $10M–$50M checks.

Where does ILLUMINA VENTURES invest?

ILLUMINA VENTURES invests in the US and Europe.